A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics
Oral activated charcoal (OAC), a potent adsorbent with no systemic absorption, has been used for centuries to treat poisoning. Recent studies have suggested its potential efficacy in protecting the colonic microbiota against detrimental effects of antibiotics. In a dose-finding safety and feasibilit...
Main Authors: | Armin Rashidi, Sathappan Karuppiah, Maryam Ebadi, Ryan Shanley, Alexander Khoruts, Daniel J. Weisdorf, Christopher Staley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197061/?tool=EBI |
Similar Items
-
A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics.
by: Armin Rashidi, et al.
Published: (2022-01-01) -
Loss of microbiota-derived protective metabolites after neutropenic fever
by: Armin Rashidi, et al.
Published: (2022-04-01) -
Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia
by: Armin Rashidi, et al.
Published: (2022-08-01) -
75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial
by: Armin Rashidiryam Ebadi, et al.
Published: (2021-03-01) -
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial
by: Armin Rashidi, et al.
Published: (2024-12-01)